• primary rheumatologist (WHO 1270 / 14.08.2019)
• 2013 doctor of medicine with the thesis “Accelerated atherosclerosis in systemic lupus erythematosus” (6508 / 19.12.2012) Scientific leader: Prof. Univ. Dr.RodicaChirieac
• 2008 master “Diseases with immune determinism” (G / 0059491) Iasi, Faculty of General Medicine
• 2006 licensed (Y 0083489) UMF “Gr.T.Popa” Iasi, Faculty of General Medicine

• 2021- present, Lecturer at the Faculty of Medicine and Biological Sciences, “Ștefancel Mare” University of Suceava.
• 2020 – 2021, Lecturer at the Department of Health and Human Development, Faculty of Physical Education and Sports, “Stefan cel Mare” University of Suceava.

• semeiology
• pathophysiology

• IASP Grant: Musculoskeletal Pain Academy, 2011, IASP Developing Countries Project: Initiative for improving pain education; jul2011-jul2012; (agreement UMF “Gr.T.Popa” Iasi no.12119 / 28.06.2011); IASP funding $ 7,000; http://www.iasp-pain.org/Education/Content.aspx?ItemNumber=954; http://www.musculoskeletal.pain-academy.com

• II. EUSTAR Clinical Project CP34: Early Accelerated Atherosclerosis in Systemic Sclerosis (SSAS), EUSTAR grant 2011-2015; UCN-EUSTAR162 (no.12428 / 30.06.2011) members of the research team: Carmen Marina Mihai, UMF Bucharest (UCN-EUSTAR 100); Valeria Ricerri, Jose Luis Rosales-Alexander (UCN-EUSTAR 094), Patricia Carreira P (UCN-EUSTAR 023), Maria Joao Salvador (UCN-EUSTAR 068), Juan José Alegre Sancho (UCN EUSTAR 123); http://www.eustar.org/ClinicalTrial.html
• III. EUSTAR Clinical Project: Very Early Diagnosis of Systemic Sclerosis VEDOSS, 2010-2015 (2020),, PROJECT manager: Prof. Dr. Marco MatucciCerinic; opinion no. ; http://www.eustar.org/Vedoss.html (6681/01 / 04.2013)
• EUSTAR Clinical Project: MEDS; http://www.eustar.org/MedsOnline.html (Opinion No 12528 / 10.07.2009)

• Musculoskeletal pain
• Accelerated atherosclerosis in SLE, RA;
• Systemic scleroderma

• primary rheumatology doctor, County Hospital „St. IoancelNou ”Suceava – competition June 2016
• Lecturer Semiology, Clinical Pharmacology, Immunology – Faculty of General Nursing – “Stefan cel Mare” University of Suceava
• scientific researcher (exam 7-8 Sep. 2015)
• rheumatology specialist (20036 / 06.01.2014)

• Codrina Ancuta, Cristina Pomîrleanu, Claudia Mihailov, RodicaChirieac, Eugen Ancuta¸, Cristina Iordache, Codruta Bran, OanaTanculescu, Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis, Joint Bone Spine 87 (2020) 235-239
• Belibou, C., Ancuţa, C., Ancuţa, E., Filoş, C. and Chirieac, R., 2012. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus. Rom J MorpholEmbryol, ”53 (1), pp.29-34. IF = 1.5, WOS: 000302266600004 https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 10
• Belibou C, Ancuţa C, Miu S., Ancuţa E., Păstrăguş C., Chireac R. Contributions to the clinical-biological knowledge of systemic lupus erythematosus and the relationship with indicators of tissue activity and destruction. Rev. Med. Chir. Shock. Med. Nat., Iaşi – 2012 – vol. 116, no. 1
• Cristina Pomârleanu, Alexandra Jitaru, Raluca Maxim, CodruțaBelibou, CodrinaAncuța: A predictive model for Simplified Disease Activity Index (SDAI) remission in rheumatoid arthritis. Romanian Journal of Rheumatology, Bucharest-2015-vol.24, no.1
• Pomîrleanu C, Jitaru A, Maxim R, Belibou C, Ancuta C, Can SDAI remission be predicted in patients with established rheumatoid arthritis treated with anti-TNF agents? Romanian Journal of Rheumatology, Bucharest, 2015, vol. 24, no. 2
• Macovei, Luana; Ancuta, Codrina; Belibou, Codruta, Chirieac, Rodica, Study of bone mineral density in patients with rheumatoid arthritis. [Bone mineral density in patients with rheumatoid arthritis]. Medical-surgical journal of the Society of Physicians and Naturalists of Iasi, Volume: 115 Issue: 3 2010 Pages: 723-30, ISSN: 0048-7848.
• Ancuţa, C., E. Ancuţa, S. Miu, C. Iordache, C. Belibou, and R. Chirieac. Adalimumab therapy in patients with active rheumatoid arthritis. Medical-surgical journal of the Society of Physicians and Naturalists of Iasi 113, no. 3 2009: 710-715.
• Codrina Ancuta, C. Belibou, R, Maxim, AE Petrea, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Aspects of immunogenicity and clinical efficacy of long-term TNF inhibitors administered to patients with rheumatic immune pathology mediated (preliminary study). Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
• C. Pomirleanu, A.E. Trifan, G. Strugariu, L. Petrariu, R. Maxim, C. Belibou, Codrina Ancuta, The impact of gouty arthropathy on disability and quality of life, Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
• Codrina Ancuta, C. Belibou, R. Maxim, I. Horgot, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Long-term efficacy of TNF inhibitors and persistence on biological therapy in psoriatic arthropathy. Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
• C. Pomirleanu, R. Maxim, A.E. Trifan, I. Resmerita, G. Strugariu, L. Petrariu, C. Belibou, Codrina Ancuta, C-reactive protein, biomarker of the severity of knee osteoarthritis? Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
• Codrina Ancuta, C. Belibou, R. Maxim, A.E. Petrea, C. Pomirleanu, R. Chirieac, Bone mineral density and the risk of fracture in systemic scleroderma – the experience of an EUSTAR center. Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2

• Codrina, A., Cristina Pomirleanu, Georgiana Strugariu, Luiza Petrariu, Raluca Paiu, Eugen Ancuta, Codruta Bran, and RodicaChirieac. FRI0076 The Risk Of Tuberculosis In Patients With Immune-Mediated Rheumatic Disorders Receiving Biological Therapy: A 15-Year Experience In A Romanian Cohort. 2019: 699-700. Annals Of The Rheumatic Diseases, IF = 14,299, WOS: 000472207102119

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=43&SID=F329RQI8ErdzTvcIcEj&page=1&doc=1

• Codrina, A, Cristina Pomirleanu, Raluca Paiu, Georgiana Strugariu, Luiza Petrariu, Eugen Ancuta, Codruta Bran, RodicaChirieac, and Claudia Mihailov. 2019 FRI0382 Ten-year retention rates of first-line biological agent in axial spondylarthritis in daily practice: a romanian multicentre experience. Annals Of The Rheumatic Diseases, IF = 14,299, WOS: 000472207102426

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=43&SID=F329RQI8ErdzTvcIcEj&page=1&doc=2

• Ancuta, C., Belibou, C., Pomirleanu, C., Mihai, C., Ancuta, I., Carreira, P., Alexander, J., Alegre, J., Riccieri, V., Salvador, M. and Chirieac, R., 2015. Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort. Arthritis & Rheumatology, 67, pp.2287-2288 IF = 9.002, WOS: 000370860203309

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode = GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 6

• Ancuta, C., C. Pomirleanu, R. Maxim, C. Belibou, E. Ancuta, and R. Chirieac. Bone mineral density and fracture risk in a cohort of systemic lupus erythematosus women in clinical and experimental rheumatology, vol 34, no. 4, pp. S89-S89. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2016. IF = 3.238, WOS: 000390289700209

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 1

• Ancuta, C., C. Pomirleanu, R. Maxim, C. Belibou, E. Ancuta, C. Iordache, and R. Chirieac. Determinants of quality of life in systemic lupus erythematosus: a single center experience in Clinical and Experimental Rheumatology, vol 34, no. 4, pp. S47-S47. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2016. IF = 3.238, WOS: 000390289700102

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 2

• Ancuta, C., Pomirleanu, C., Belibou, C., Maxim, R., Petrariu, L., Strugariu, G. and Chirieac, R., 2016. THU0129 Clinical outcomes of immunogenicity in rheumatoid arthritis patients under anti-TNF biologics: results from an observational study. ANNALS OF THE RHEUMATIC DISEASES, 2016: 227-227. IF = 14,299, WOS: 000401523101111,

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1& SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 3

• Pomirleanu, C., Strugariu, G., Belibou, C., Maxim, R., Petrariu, L. and Ancuta, C., 2016. FRI0483 Is There A Difference in Autoimmune Myopathies with and without Raynaud’s Phenomenon? A Capillaroscopy Study. 613-613. ANNALS OF THE RHEUMATIC DISEASES, 2016. IF = 14,299, WOS: 000401523103077.

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 4

• Ancuta, Codrina, CodrutaBelibou, Cristina Pomirleanu, Eugen Ancuta, and RodicaChirieac. Patient Reported Outcomes after Failure of a TNF alpha Inhibitor in Rheumatoid Arthritis-Switching to Rituximab or Cycling between Anti-TNFs? In Clinical And Experimental Rheumatology, Vol. 32, No. 4, pp. S38-S38. Via Santa Maria 31, 56126 Pisa, Italy: Clinical &Exper Rheumatology, 2014. IF = 3,238, WOS: 000440319800084

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 8

• Ancuta, C. M., Belibou, C., Ancuta, E., Miu, S., &Chirieac, R. 2013. THU0102 EULAR-DAS28 versus RAPID3 for treatment monitoring in patients with rheumatoid arthritis treated with rituximab. Annals of the Rheumatic Diseases, 71 (Suppl 3), 188-189. IF = 14,299. IF = 14,299, WOS: 000208898501037.

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 1 & doc = 9

• Ancuta, Codrina, Eugen Ancuta, Cristina Iordache, Codruta Belibou, and Rodica Chirieac. Assessment of health related quality of life with monthly ibandronate in postmenopausal osteoporosis. In Osteoporosis International, Vol. 22, pp. 308-309. 236 Grays Inn Rd, 6th Floor, London Wc1x 8hl, England: Springer London LTD, 2011. IF = 3.83, WOS: 000288662000554

https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid = 1 & SID = F329RQI8ErdzTvcIcEj & page = 2 & doc = 11

• Ancuta, C., L. Macovei, E. Ancuta, C. Belibou, and R. Chirieac. New Horizons For Joint Protection In Rheumatoid Arthritis Under A

• Oral presentation Codruţa Bran, E Ancuţa, Codrina Mihaela Ancuta: “Biological therapy and pregnancy in rheumatic disease with immune determinism” Suceava Medical Days, May 2019
• Poster presentation C. Bran, C. Belibou, E. Ancuta, C. Ancuta- Long-term survival on etanercept in patients wirhaxSpA: preliminary data in a Romanian cohort, CORA, Florence 14-16 Mar 2019
• Poster presentation C. Bran, C. Belibou, E. Ancuta, C. Ancuta- A challenging case of rheumatoid arthritis with sacroiliitis, CORA, Florence 14-16 Mar 2019
• Poster presentation Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from the SSAS Cohort American Congress of Rheumatology, ACR, San Francisco, USA, Nov 2015
• Necrotizing myositis with positive anti-SRP antibodies clinical case presentation in the plenary session “Myositis” – Chirieac, C. Pomarleanu. L. Petrariu, G. Strugariu, C. Belibou- National Congress of Rheumatology, Bucharest 23-26 Sep 2015
• Leukopenia, Leukocytosis, Thrombocytopenia, Thrombocytosis, Erythrocytosis in Hematological Manifestations in Rheumatic Diseases – Summer School of Rheumatology, Poiana Brașov July 2015
• May 8, 2015 in the course III Systemic Scleroderma – Skin Manifestations
• Apr 24, 2015 in course II Systemic scleroderma: Muscle damage
• March 20, 2015 in the course I Systemic Scleroderma: Diagnostic Criteria
• New therapies in rheumatoid arthritis – oral presentation Rehabilitation Hospital Days March 23-27, Iași, 2015
• SLE clinical case presentation – Woerwag event, Sinaia May 5-6, 2015
• Poster presentation Bone mineral density and fracture risk in systemic scleroderma: the experience of an EUSTAR center National Congress of Rheumatology, Bucharest, Sep 2015
• Codrina Ancuta, C. Belibou, R. Maxim, A.E. Petrea, C. Pomirleanu, R. Chirieac, Bone mineral density and risk of fracture in systemic scleroderma – the experience of an EUSTAR center – oral presentation, National Congress of Rheumatology, Sep 2015
• Codrina Ancuta, C. Belibou, R. Maxim, I. Horgot, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Long-term efficacy of TNF inhibitors and persistence on biological therapy in psoriatic arthropathy, National Congress of Rheumatology, Sep 2015
• C. Pomirleanu, R. Maxim, A.E.Trifan, I. Resmerita, G. Strugariu, L. Petrariu, C. Belibou, 
• Codrina Ancuta, C-reactive protein, biomarker of the severity of knee osteoarthritis? National Congress of Rheumatology, Sep 2015
• Codrina Ancuta, C. Belibou, R, Maxim, AE Petrea, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Aspects of immunogenicity and clinical efficacy of long-term TNF inhibitors administered to patients with rheumatic immune pathology mediated (preliminary study), National Congress of Rheumatology, Sep 2015
• C. Pomirleanu, A.E. Trifan, G. Strugariu, L. Petrariu, R. Maxim, C. Belibou, Codrina Ancuta, The impact of gouty arthropathy on disability and quality of life, National Congress of Rheumatology, Sep 2015